{"ATC Code":"J01CE01","Abbreviation":"","Aliases":["penicillin g","Benzyl penicillin","Free penicillin II","Pencillin G","Benzylpenicillin G","Bencilpenicilina","Dropcillin","Free penicillin G","Gelacillin","Liquacillin"],"Biological Half-Life":"In adults with normal renal function is reportedly 0.4–0.9 hours","CAS":"61-33-6","ChEBI":"CHEBI:18208","ChEMBL":"CHEMBL29","ChemicalClasses":["amino acid"],"Chirality":"absolute","ChiralityAminoAcid":true,"Color/Form":"AMORPHOUS WHITE POWDER","Density":"MP 106-110 °C (WITH DECOMPOSITION); DENSITY 1.255-1.256; AQ SOLN ARE DEXTROROTATORY; SOLUBILITIES @ 28 °C: 6.8 MG/ML IN WATER, GREATER THAN 20 MG/ML IN METHANOL, 0.075 MG/ML IN BENZENE, 1.05 IN TOLUENE /PENICILLIN G PROCAINE/ g/cm\u003csup\u003e3\u003c/sup\u003e","Dosing Info":[],"Drug Classes":"Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antibacterial Agents; Penicillins","Drug Indication":"For use in the treatment of severe infections caused by penicillin G-susceptible microorganisms when rapid and high penicillin levels are required such as in the treatment of septicemia, meningitis, pericarditis, endocarditis and severe pneumonia.","Drug Warnings":"WHEN MASSIVE DOSES OF PENICILLIN G SODIUM ARE USED, CONSIDERABLE SODIUM LOAD IS INTRODUCED, WHICH EXPANDS EXTRACELLULAR SPACE \u0026 MAY CAUSE EDEMA IN PT WITH HEART FAILURE. /PENICILLIN G SODIUM/","DrugClasses":[],"EINECS":"200-506-3","EliminationHalfLife":"30\u0026nbsp;min","European Community (EC) Number":"200-506-3","FDA Pharmacological Classification":"Q42T66VG0C","FullSalts":["Sodium benzylpenicillin"],"HMDB ID":"HMDB0015186","HeavyAtomCount":23,"Human Drugs":"Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antibacterial Agents; Penicillins","IUPACName":"(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","InChI":"InChI=1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1","InChIKey":"JGSARLDLIJGVTE-MBNYWOFBSA-N","MeSH Pharmacological Classification":"Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)","Melting Point":"214-217 °C","MolecularFormula":"C\u003csub\u003e16\u003c/sub\u003eH\u003csub\u003e18\u003c/sub\u003eN\u003csub\u003e2\u003c/sub\u003eO\u003csub\u003e4\u003c/sub\u003eS","MolecularWeight":"334.4 g/mol","Opticalactivity":"UNSPECIFIED","Pharmacodynamics":"Penicillin G is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name \"penicillin\" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Penicillin G has \u003ci\u003ein vitro\u003c/i\u003e activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of penicillin G results from the inhibition of cell wall synthesis and is mediated through penicillin G binding to penicillin binding proteins (PBPs). Penicillin G is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases.","Physical Description":"Solid","PrevSalts":["sodium"],"PubChemId":5904,"Record Description":["Benzylpenicillin is a penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group. It has a role as an antibacterial drug, an epitope and a drug allergen. It is a penicillin allergen and a penicillin. It is a conjugate acid of a benzylpenicillin(1-).","Penicillin G (potassium or sodium) is an antibacterial prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain serious bacterial infections, such as pneumonia, meningitis, gonorrhea, syphilis, and others.","Pneumonia and syphilis can be opportunistic infections (OI) of HIV.","Benzylpenicillin (Penicillin G) is narrow spectrum antibiotic used to treat infections caused by susceptible bacteria. It is a natural penicillin antibiotic that is administered intravenously or intramuscularly due to poor oral absorption. Penicillin G may also be used in some cases as prophylaxis against susceptible organisms.   Natural penicillins are considered the drugs of choice for several infections caused by susceptible gram positive aerobic organisms, such as *Streptococcus pneumoniae*, groups A, B, C and G streptococci, nonenterococcal group D streptococci, viridans group streptococci, and non-penicillinase producing staphylococcus. Aminoglycosides may be added for synergy against group B streptococcus (*S. agalactiae*), *S. viridans*, and *Enterococcus faecalis*. The natural penicillins may also be used as first or second line agents against susceptible gram positive aerobic bacilli such as *Bacillus anthracis*, *Corynebacterium diphtheriae*, and *Erysipelothrix rhusiopathiae*. Natural penicillins have limited activity against gram negative organisms; however, they may be used in some cases to treat infections caused by *Neisseria meningitidis* and *Pasteurella*. They are not generally used to treat anaerobic infections. Resistance patterns, susceptibility and treatment guidelines vary across regions.","Penicillin g is a Penicillin-class Antibacterial.","Penicillin G has been reported in Sarocladium strictum, Hohenbuehelia grisea, and other organisms with data available.","Penicillin G is a broad-spectrum, beta-lactam naturally occurring penicillin antibiotic with antibacterial activity. Penicillin G binds to and inactivates the penicillin binding proteins (PBPs) located inside the bacterial cell wall. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This interrupts bacterial cell wall synthesis and results in the weakening of the bacterial cell wall and eventually causing cell lysis.","BENZYLPENICILLIN is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1947 and has 3 approved and 18 investigational indications. This drug has a black box warning from the FDA.","A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission.","See also: Penicillin G Potassium (has salt form); Penicillin G Procaine (active moiety of); Penicillin G Sodium (has salt form) ... View More ...","Benzylpenicillin is a penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group. It has a role as an antibacterial drug, an epitope and a drug allergen. It is a penicillin allergen and a penicillin. It is a conjugate acid of a benzylpenicillin(1-).","LiverTox|Antimicrobial|Antibacterial|Penicillin, 1st gen"],"References":[{"Name":"Wikipedia","Urls":[{"Link":"https://en.wikipedia.org/wiki/Benzylpenicillin","Name":"Benzylpenicillin","Sub":false}]},{"Name":"Wikidata","Urls":[{"Link":"https://www.wikidata.org/wiki/Q258450","Name":"Benzylpenicillin","Sub":false}]},{"Name":"DrugBank","Urls":[{"Link":"https://go.drugbank.com/drugs/DB01053","Name":"Benzylpenicillin","Sub":false}]},{"Name":"PubChem","Urls":[{"Link":"https://pubchem.ncbi.nlm.nih.gov/compound/5904","Name":"Benzylpenicillin","Sub":false}]},{"Name":"ChEMBL","Urls":[{"Link":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL29","Name":"Benzylpenicillin","Sub":false}]},{"Name":"ChEBI","Urls":[{"Link":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:18208","Name":"Benzylpenicillin","Sub":false}]},{"Name":"Common Chemistry","Urls":[{"Link":"https://commonchemistry.cas.org/detail?cas_rn=61-33-6","Name":"Benzylpenicillin","Sub":false}]},{"Name":"HMDB","Urls":[{"Link":"https://hmdb.ca/metabolites/HMDB0015186","Name":"Benzylpenicillin","Sub":false}]},{"Name":"KEGG","Urls":[{"Link":"https://www.kegg.jp/entry/C05551","Name":"Benzylpenicillin","Sub":false}]},{"Name":"UNII","Urls":[{"Link":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/Q42T66VG0C","Name":"Benzylpenicillin","Sub":false}]},{"Name":"EPA DSSTox","Urls":[{"Link":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID5046934","Name":"Benzylpenicillin","Sub":false}]}],"SMILES":"CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C","Salts":["sodium"],"SaltsAcidCount":[1],"SaltsAmineCount":[1],"SaltsUNII":["YS5LY7JF4N"],"Scheduling":[],"Solubility":"Slightly soluble (210 mg/L)","Stability/Shelf Life":"Solutions of the drugs retain substantially full potency for several days when stored @ a temp less than 15 °C, but are rapidly inactivated in the presence of acids, alkali hydroxides, glycerin, or oxidizing agents. /Penicillin G potassium or sodium/","StoreUNII":["Q42T66VG0C"],"StructureBase64":"<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" height="140.12mm" version="1.2" viewBox="0 0 61.975 140.12" width="61.975mm">
      
    <desc>Generated by the Chemistry Development Kit (http://github.com/cdk)</desc>
      
    <g fill="#FF0D0D" stroke="#000000" stroke-linecap="round" stroke-linejoin="round" stroke-width=".7">
            
        <rect fill="#FFFFFF" height="141.0" stroke="none" width="62.0" x=".0" y=".0"/>
            
        <g class="mol" id="mol1">
                  
            <line class="bond" id="mol1bnd1" x1="22.215" x2="14.577" y1="6.547" y2="19.735"/>
                  
            <line class="bond" id="mol1bnd2" x1="14.577" x2="28.453" y1="19.735" y2="25.941"/>
                  
            <line class="bond" id="mol1bnd3" x1="28.453" x2="27.281" y1="25.941" y2="37.28"/>
                  
            <path class="bond" d="M11.9 43.93l.145 .685l11.882 -1.119l-.354 -1.674l-.354 -1.675z" fill="#000000" id="mol1bnd4" stroke="none"/>
                  
            <line class="bond" id="mol1bnd5" x1="11.973" x2="6.274" y1="44.272" y2="34.306"/>
                  
            <line class="bond" id="mol1bnd6" x1="14.577" x2="6.79" y1="19.735" y2="28.37"/>
                  
            <line class="bond" id="mol1bnd7" x1="11.973" x2="15.123" y1="44.272" y2="59.183"/>
                  
            <line class="bond" id="mol1bnd8" x1="15.123" x2="30.034" y1="59.183" y2="56.033"/>
                  
            <line class="bond" id="mol1bnd9" x1="27.69" x2="30.034" y1="44.942" y2="56.033"/>
                  
            <g class="bond" id="mol1bnd10">
                        
                <line x1="29.677" x2="40.277" y1="54.346" y2="61.248"/>
                        
                <line x1="28.347" x2="38.947" y1="56.39" y2="63.292"/>
                      
                <line class="hi" stroke="#FF0D0D" x1="40.277" x2="34.977000000000004" y1="61.248" y2="57.797"/>
                <line class="hi" stroke="#FF0D0D" x1="38.947" x2="33.647000000000006" y1="63.292" y2="59.841"/>
            </g>
                  
            <path class="bond" d="M15.416 59.374l-.586 -.382l-7.008 8.464l1.344 .875l1.344 .876z" fill="#000000" id="mol1bnd11" stroke="none"/>
                  
            <line class="bond" id="mol1bnd12" x1="8.685" x2="13.709" y1="75.653" y2="85.542"/>
                  
            <g class="bond" id="mol1bnd13">
                        
                <line x1="13.071" x2="25.335" y1="84.287" y2="84.945"/>
                        
                <line x1="12.941" x2="25.204" y1="86.722" y2="87.379"/>
                      
                <line class="hi" stroke="#FF0D0D" x1="25.335" x2="19.203" y1="84.945" y2="84.616"/>
                <line class="hi" stroke="#FF0D0D" x1="25.204" x2="19.0725" y1="87.379" y2="87.0505"/>
            </g>
                  
            <line class="bond" id="mol1bnd14" x1="13.709" x2="5.393" y1="85.542" y2="98.313"/>
                  
            <line class="bond" id="mol1bnd15" x1="5.393" x2="12.295" y1="98.313" y2="111.9"/>
                  
            <g class="bond" id="mol1bnd16">
                        
                <line x1="27.522" x2="12.295" y1="112.712" y2="111.9"/>
                        
                <line x1="25.986" x2="13.57" y1="115.072" y2="114.41"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd17" x1="27.522" x2="34.424" y1="112.712" y2="126.3"/>
                  
            <g class="bond" id="mol1bnd18">
                        
                <line x1="26.099" x2="34.424" y1="139.075" y2="126.3"/>
                        
                <line x1="24.824" x2="31.612" y1="136.565" y2="126.148"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd19" x1="26.099" x2="10.873" y1="139.075" y2="138.263"/>
                  
            <g class="bond" id="mol1bnd20">
                        
                <line x1="3.97" x2="10.873" y1="124.676" y2="138.263"/>
                        
                <line x1="6.782" x2="12.409" y1="124.827" y2="135.904"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd21" x1="12.295" x2="3.97" y1="111.9" y2="124.676"/>
                  
            <g class="bond" id="mol1bnd22">
                        
                <line x1="28.278" x2="28.628" y1="25.638" y2="26.244"/>
                        
                <line x1="30.332" x2="30.973" y1="24.115" y2="25.227"/>
                        
                <line x1="32.386" x2="33.319" y1="22.593" y2="24.21"/>
                        
                <line x1="34.439" x2="35.665" y1="21.07" y2="23.192"/>
                        
                <line x1="36.493" x2="38.01" y1="19.548" y2="22.175"/>
                        
                <line x1="38.547" x2="40.356" y1="18.025" y2="21.157"/>
                        
                <line x1="40.601" x2="42.701" y1="16.502" y2="20.14"/>
                      
            </g>
                  
            <g class="bond" id="mol1bnd23">
                        
                <line x1="41.651" x2="41.651" y1="18.321" y2="7.002"/>
                        
                <line x1="44.09" x2="44.09" y1="16.913" y2="7.002"/>
                      
                <line class="hi" stroke="#FF0D0D" x1="41.651" x2="41.651" y1="7.001999999999999" y2="12.6615"/>
                <line class="hi" stroke="#FF0D0D" x1="44.09" x2="44.09" y1="7.001999999999999" y2="11.9575"/>
            </g>
                  
            <line class="bond" id="mol1bnd24" x1="41.651" x2="51.566" y1="18.321" y2="24.045"/>
                  
            <line class="bond" id="mol1bnd25" x1="14.577" x2="2.257" y1="19.735" y2="10.764"/>
                  
            <path class="atom" d="M28.824 43.572h-.72l-2.619 -4.066h-.03q.012 .238 .03 .595q.023 .357 .023 .733v2.738h-.565v-4.899h.714l2.608 4.054h.029q-.006 -.108 -.017 -.328q-.012 -.22 -.024 -.476q-.006 -.262 -.006 -.482v-2.768h.577v4.899z" fill="#3050F8" id="mol1atm4" stroke="none"/>
                  
            <path class="atom" d="M5.942 32.161q-.0 .649 -.477 1.018q-.47 .363 -1.268 .363q-.416 -.0 -.768 -.066q-.345 -.059 -.577 -.172v-.59q.244 .113 .607 .203q.369 .089 .762 .089q.548 -.0 .828 -.214q.279 -.215 .279 -.578q.0 -.238 -.107 -.399q-.101 -.166 -.351 -.309q-.25 -.143 -.697 -.298q-.625 -.226 -.946 -.554q-.316 -.333 -.316 -.898q.0 -.393 .197 -.667q.202 -.28 .554 -.429q.357 -.155 .815 -.155q.405 .0 .738 .078q.34 .071 .613 .196l-.196 .53q-.25 -.113 -.548 -.184q-.297 -.078 -.625 -.078q-.458 .0 -.69 .197q-.232 .196 -.232 .518q-.0 .244 .101 .41q.107 .167 .339 .298q.232 .125 .631 .28q.429 .155 .726 .339q.298 .179 .453 .435q.155 .25 .155 .637z" fill="#C6C62C" id="mol1atm6" stroke="none"/>
                  
            <path class="atom" d="M45.064 64.346q.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.5 .315 -1.244 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.244 -.572 -.244 -1.334q-.0 -.75 .244 -1.309q.25 -.566 .756 -.882q.506 -.315 1.274 -.315q.732 -.0 1.232 .315q.5 .31 .756 .876q.256 .565 .256 1.327zM41.201 64.346q-.0 .923 .386 1.459q.393 .529 1.221 .529q.839 .0 1.22 -.529q.387 -.536 .387 -1.459q.0 -.929 -.387 -1.452q-.381 -.524 -1.208 -.524q-.834 -.0 -1.227 .524q-.392 .523 -.392 1.452z" id="mol1atm9" stroke="none"/>
                  
            <g class="atom" id="mol1atm10">
                        
                <path d="M8.748 74.404h-.721l-2.619 -4.066h-.03q.012 .238 .03 .596q.024 .357 .024 .732v2.738h-.566v-4.899h.715l2.607 4.054h.03q-.006 -.107 -.018 -.328q-.012 -.22 -.024 -.476q-.006 -.262 -.006 -.482v-2.768h.578v4.899z" fill="#3050F8" stroke="none"/>
                        
                <path d="M4.305 74.404h-.62v-2.286h-2.512v2.286h-.613v-4.899h.613v2.071h2.512v-2.071h.62v4.899z" fill="#3050F8" stroke="none"/>
                      
            </g>
                  
            <path class="atom" d="M31.186 86.355q.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.5 .315 -1.244 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.244 -.572 -.244 -1.334q-.0 -.75 .244 -1.309q.25 -.566 .756 -.881q.506 -.316 1.274 -.316q.732 .0 1.232 .316q.5 .309 .756 .875q.256 .565 .256 1.327zM27.323 86.355q-.0 .923 .387 1.459q.393 .53 1.22 .53q.84 -.0 1.221 -.53q.386 -.536 .386 -1.459q.0 -.928 -.386 -1.452q-.381 -.524 -1.209 -.524q-.833 -.0 -1.226 .524q-.393 .524 -.393 1.452z" id="mol1atm12" stroke="none"/>
                  
            <path class="atom" d="M45.13 3.078q-.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.501 .315 -1.245 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.244 -.572 -.244 -1.334q.0 -.75 .244 -1.309q.25 -.566 .756 -.881q.506 -.316 1.274 -.316q.732 .0 1.233 .316q.5 .309 .756 .875q.256 .565 .256 1.327zM41.266 3.078q-.0 .923 .387 1.459q.393 .53 1.22 .53q.84 -.0 1.221 -.53q.387 -.536 .387 -1.459q-.0 -.929 -.387 -1.452q-.381 -.524 -1.209 -.524q-.833 -.0 -1.226 .524q-.393 .523 -.393 1.452z" id="mol1atm21" stroke="none"/>
                  
            <g class="atom" id="mol1atm22">
                        
                <path d="M57.109 25.938q-.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.501 .315 -1.245 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.244 -.572 -.244 -1.334q.0 -.75 .244 -1.309q.25 -.566 .756 -.881q.506 -.316 1.274 -.316q.732 .0 1.233 .316q.5 .309 .756 .875q.256 .565 .256 1.327zM53.245 25.938q-.0 .923 .387 1.459q.393 .53 1.22 .53q.84 -.0 1.221 -.53q.387 -.536 .387 -1.459q-.0 -.929 -.387 -1.452q-.381 -.524 -1.209 -.524q-.833 -.0 -1.226 .524q-.393 .523 -.393 1.452z" stroke="none"/>
                        
                <path d="M61.415 28.391h-.619v-2.286h-2.513v2.286h-.613v-4.9h.613v2.072h2.513v-2.072h.619v4.9z" stroke="none"/>
                      
            </g>
                
            <line class="hi" id="mol1bnd3" stroke="#3050F8" x1="27.281" x2="27.866999999999997" y1="37.28" y2="31.610500000000002"/>
            <line class="hi" id="mol1bnd5" stroke="#C6C62C" x1="6.274" x2="9.1235" y1="34.306" y2="39.289"/>
            <line class="hi" id="mol1bnd6" stroke="#C6C62C" x1="6.79" x2="10.6835" y1="28.37" y2="24.052500000000002"/>
            <line class="hi" id="mol1bnd9" stroke="#3050F8" x1="27.69" x2="28.862000000000002" y1="44.942" y2="50.4875"/>
            <line class="hi" id="mol1bnd12" stroke="#3050F8" x1="8.685" x2="11.197" y1="75.653" y2="80.5975"/>
            <line class="hi" id="mol1bnd12" stroke="#3050F8" x1="8.685" x2="11.197" y1="75.653" y2="80.5975"/>
            <line class="hi" id="mol1bnd24" stroke="#FF0D0D" x1="51.566" x2="46.60850000000001" y1="24.045" y2="21.183"/>
        </g>
          
    </g>
    
</svg>
","Therapeutic Uses":"Convulsants; GABA Modulators; Penicillins","Title":"Benzylpenicillin","UNII":"Q42T66VG0C","Wikidata":"Q258450","Wikipedia":"Benzylpenicillin","XLogP":1.8,"pH":"Saturated aqueous solution: 5-7.5 /Penicillin G procaine/"}